top of page
find out more
Food allergies are on the rise,
with significant social, health, and economic impact
$25B
Each year is spent on healthcare costs related to food allergies and disorders
1 in every 13 children in
the United States is affected by food allergies
Every 3 minutes anaphylaxis sends someone to the E.R.
Ukko uses its computational protein design platform to develop a pipeline of revolutionary therapeutics for life threatening allergies: modulating the immune system of allergic patients without triggering allergy
Leadership Team
Our Advisors
PROF. RAANAN SHAMIR
Chairman, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center
Team
contact
stay informed
We are building a clinically validated map of the molecular interaction between the allergen and the patient's immune system: unlocking critical knowledge about the biological mechanisms that drive human-food interactions
Using this map, we then use our AI micro-engineering platform to design new versions of the allergen that do not trigger an allergic response but still re-educate the immune system to tolerate the allergen. This allows for a whole new approach to treating allergies
bottom of page